Patent · US Active

Substituted imidazoquinolines

US9908880B2 · kind B2 · utility

2Cited by
6References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 19, 2016
Grant dateMar 6, 2018
Priority date
Expiry dateSep 19, 2036

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Imidazoquinolines of formula I that contain substituted amine or amide functionality at 1-position and that are effective as Toll like Receptor 7 activators are disclosed. These compounds are useful as anticancer agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.